Made for people

We build reliable pharma solutions that help people live healthier, better lives.

Learn More
Quality Control / GDP Compliance
Pharmacovigilance / GVP Compliance
Regulatory Support / Product Registration
Logistics & Supply Chain Management
Business Development & Market Expansion
Repackaging for Small Markets

For more than 20 years, we have been building reliable pharmaceutical partnerships across key therapeutic areas — from reproductive health and cardiology to neurology and endocrinology.

Scroll down

We build responsible partnerships

Sona Pharm — building responsible pharma partnershipsSona Pharm — building responsible pharma partnerships
Our Mission

Sona Pharm Mission

We bring science closer to people, make health more accessible, and work with partners who believe in long-term value and responsible growth.

  • Science inspires us. It guides our thinking and helps us create solutions that are clear, reliable, and grounded in evidence.
  • People are at the center of our work. Their health, trust, and well-being shape every decision we make.
  • Partnership drives our progress. We grow through long-term, transparent, and responsible collaboration.

End-to-end product management for pharmaceutical companies

We provide integrated, science-driven support for pharmaceutical companies across the full product lifecycle: assessment, regulation, distribution, and performance.

Our Services

We drive innovation
in therapeutic fields

Sona Pharm

We advance key therapeutic fields to improve patient outcomes,
expand access to care, and build long-term value with responsible partners.

Leadership Across Markets
and Therapeutic Areas

Strong commercial performance across key categories, complemented by measurable contributions to healthcare development and system-level change.

Ophthalmology
№1

in ophthalmology promotion in Ukraine and Kazakhstan

Ophthalmology
№1

in Dry Eye Disease treatment in Ukraine

Reproductive health
45-80%

market share in Assisted Reproductive Technologies (ART) across key markets

Gastroenterology
№1

in the treatment of Irritable Bowel Syndrome with Diarrhea

Gastroenterology
№1

in the treatment of Symptomatic Uncomplicated Diverticular Disease

ENT
40%

market share in Ear Pain relief drops market in Kazakhstan

Reproductive health
№2

among the Top 10 INNs by procurement volume in Ukraine

Reproductive health

In Uzbekistan, Sona Pharm contributed to legislative changes that enabled the use of ART in infertility treatment.

*Selected market data according to Proxima Research, IQVIA, 2025. Additional business and market information based on internal company data.

Trusted by Leading Global Pharmaceutical Partners.
Chosen by leading pharmaceutical companies across global markets.

Aesculapius logo
Pharma International logo
Alfa Wassermann logo
Starpharma logo
Ursapharm logo
Bionorica logo
Merz logo
Visus logo
Pharmacare logo
Vita Vitro logo
Coripharma logo

Sona Pharm Success Story.
More than 20 Years of Success

Foundation & first alliances

2003 – 2008

  • Sona Pharm founded in Ukraine (2003)
  • Joined the European Business Association (EBA), Ukraine (2005)
  • Strategic partnership with URSAPHARM established (2006)
  • Strategic partnerships with Alfasigma and Magis established (2008)

Regional expansion

2011 – 2015

  • Expanded into Kazakhstan and Moldova
  • Joined the Association of International Pharmaceutical Manufacturers (AIPM), Kazakhstan (2011)
  • Grew the product portfolio into new therapeutic areas
  • Strategic partnership with Pharmathen established (2015)

International platform

2016 – 2018

  • Established a European (Estonian) legal entity (2016)
  • Launched the annual Fertility Awards (2016)
  • Entered Uzbekistan, Georgia and Armenia (2018)
  • Established Biomedica CRO (2018)

Scientific leadership

2019 – 2021

  • Launched the first multidisciplinary scientific conference (2019)
  • Helped catalyse the first legislation legalising IVF in Uzbekistan (2019)
  • Established the first National advisory expert board across therapeutic areas (2020)
  • Became the #1 company in Ukraine's Dry Eye market (2021)

Scale & clinical recognition

2022 – 2024

  • Entered Mongolia and consolidated the group as Sona Pharm (2022–2023)
  • Rifaximin included in Ukraine's MoH unified clinical protocols — IBD (2023) and liver cirrhosis (2024)
  • Ranked No. 2 among pharmaceutical suppliers to private clinics in Ukraine (follitropin alfa portfolio)
  • Launched the annual Summer and Winter Schools of Reproductive Medicine
  • New strategic partnerships — Biocodex and VISUfarma (2024)

Recognition & new frontiers

2025 – 2026

  • Alfa Normix "Prescription Drug of the Year"; Hylo-Comod leading Dry Eye brand — Panacea Awards (2025)
  • Joined APRaD (EFPIA-affiliated), Ukraine (2025)
  • New legal entity established — Sona Swiss (2026)
  • Launched Sona Academy and the Glaucoma PRO educational platform (2026)
  • Preparing to enter new international markets

A growing presence across
Europe and Central Asia.
business and education

Current Presence

  • Ukraine
  • Moldova
  • Estonia
  • Georgia
  • Armenia
  • Kazakhstan
  • Uzbekistan
  • Turkmenistan
  • Mongolia

Near-Term Expansion

  • Sweden
  • Finland
  • Denmark
  • Latvia
  • Lithuania
  • Poland
  • Slovenia
  • Croatia
  • Greece

A team of pharmaceutical industry professionals

A multidisciplinary group of experts united by one standard of responsibility. Focused on long-term value, reliable execution, and partnerships built on trust.

Ostap Kupnovytskyi
Rauno Pukonen
Vitalii Gordienko
Denis Golubchykov

Sona News

View all